Merck Shareholders Can See Documents Company Gave to Government
Merck & Co. Inc. has already paid nearly $1 billion to the federal government to resolve claims that it misbranded its painkiller Vioxx. To make matters worse, the drug giant has now lost a bid to keep Merck's shareholders from seeing potentially damaging documents that the company turned over to the U.S. Department of Justice.
This premium content is reserved for New Jersey Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now